Here's what the trials have shown: Phase 1b Trial Results (Lancet 2022) The initial Phase 1b study evaluated retatrutide safety, tolerability, and pharmacokinetics in 72 adults with type 2 diabetes over 12 weeks
Peptides work alongside, not instead of, metabolic control
Enhancing GSH, mainly through NAC, GSH precursors rich in cysteine (whey protein, whey protein isolate rich in cysteine) or pro-GSH compound administration, becomes a potential treatment option for inflammatory diseases by reducing oxidative stress and cytokine expression especially in diabetic patients that also are at risk of more severe COVID-19 disease (299)
Chronic inflammation Conditions where persistent inflammation is driving tissue damage or slowing recovery
At VYVE Wellness, we tailor your protocol depending on the type and severity of arthritis you have
For example, in studies, BPC-157 has shown promise in healing tendon-to-bone injuries much quicker than traditional treatments